The Journal of Immunology, Vol 155, Issue 6 3037-3048, Copyright © 1995 by American Association of Immunologists

ARTICLES

Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing

M Nonaka, T Miwa, N Okada, M Nonaka and H Okada
Department of Molecular Biology, Nagoya City University School of Medicine, Japan.

Human decay-accelerating factor (DAF, CD55), which is one of the regulators of complement activation (RCA), prevents complement activation on homologous cell membranes, resulting in a functional discrimination between self cells and invading microorganisms. DAF is a glycosylphosphatidylinositol (GPI)-anchored glycoprotein and has been identified at the molecular level only in primates. We have isolated guinea pig DAF cDNA clones from a spleen library and identified six different classes. All encode the same four short consensus repeat domains with 58% amino acid sequence identity to human DAF, but show variability in the C-terminal region. Alternative splicing of two optional exons generates transmembrane, GPI-anchored, and secreted forms of guinea pig DAF, and differential usage of splice sites in the single exon composed of internally quintuplicated sequences generates variable Ser/Thr-rich regions. Multiple isoforms were expressed ubiquitously in all tissues and cells tested. Similar variability in the Ser/Thr-rich region has been reported in human membrane cofactor protein (MCP), another membrane inhibitor of the RCA family. There seems to be a common ancestral sequence in DAF and MCP consisting of a Ser/Thr-rich region, but obviously multiplication occurred independently, indicating the importance of variability of the Ser/Thr- rich region for the effective regulation of complement activation.

This article has been cited by other articles:

				M. Fanjul, L. Alvarez, and E. Hollande Expression and Subcellular Localization of a 35-kDa Carbonic Anhydrase IV in a Human Pancreatic Ductal Cell Line (Capan-1) J. Histochem. Cytochem., August 1, 2007; 55(8): 783 - 794. [Abstract] [Full Text] [PDF]

				M. I. Nonaka, Y. Hishikawa, N. Moriyama, T. Koji, R. T. Ogata, A. Kudo, H. Kawakami, and M. Nonaka Complement C4b-Binding Protein as a Novel Murine Epididymal Secretory Protein Biol Reprod, December 1, 2003; 69(6): 1931 - 1939. [Abstract] [Full Text] [PDF]

				J. M. Perez de la Lastra, C. L. Harris, S. J. Hinchliffe, D. S. Holt, N. K. Rushmere, and B. P. Morgan Pigs Express Multiple Forms of Decay-Accelerating Factor (CD55), All of Which Contain Only Three Short Consensus Repeats J. Immunol., September 1, 2000; 165(5): 2563 - 2573. [Abstract] [Full Text] [PDF]

				J. Hamann, C. van Zeventer, A. Bijl, C. Molenaar, K. Tesselaar, and R. A. W. van Lier Molecular cloning and characterization of mouse CD97 Int. Immunol., April 1, 2000; 12(4): 439 - 448. [Abstract] [Full Text] [PDF]

				T. Oshima, N. Okada, T. Joh, M. Sasaki, T. Tada, N. Matsukawa, T. Nomura, H. Ohara, M. Itoh, and H. Okada Decay-Accelerating Factor in Guinea Pig Stomachs Following Ischemia Reperfusion Stress J. Immunol., January 15, 2000; 164(2): 1078 - 1085. [Abstract] [Full Text] [PDF]

				S. J. Hinchliffe, O. B. Spiller, N. K. Rushmere, and B. P. Morgan Molecular Cloning and Functional Characterization of the Rat Analogue of Human Decay-Accelerating Factor (CD55) J. Immunol., November 15, 1998; 161(10): 5695 - 5703. [Abstract] [Full Text] [PDF]

				Y. Fukuoka, J. A. Ember, and T. E. Hugli Molecular Cloning of Two Isoforms of the Guinea Pig C3a Anaphylatoxin Receptor: Alternative Splicing in the Large Extracellular Loop J. Immunol., September 15, 1998; 161(6): 2977 - 2984. [Abstract] [Full Text] [PDF]

				G. Wang, M. Nonaka, C. He, N. Okada, I. Nakashima, and H. Okada Functional Differences Among Multiple Isoforms of Guinea Pig Decay-Accelerating Factor J. Immunol., March 15, 1998; 160(6): 3014 - 3022. [Abstract] [Full Text] [PDF]

				B. N. Patel and S. David A Novel Glycosylphosphatidylinositol-anchored Form of Ceruloplasmin Is Expressed by Mammalian Astrocytes J. Biol. Chem., August 8, 1997; 272(32): 20185 - 20190. [Abstract] [Full Text] [PDF]